Navigating the GLP-1 Opportunity In China: Strategic Imperatives For Western Pharma (Subscription requried)
China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline (Subscription required)
China, where obesity levels are low, becomes hotbed for weight loss drug trials (Subscription required)
Mainland Chinese market for weight loss and diabetes drugs to soon be more crowded: report
Intergenerational wealth transfer is major client priority as financial planning firms invest in technology to enhance client experience
Allowing commercial access to UK Biobank and NHS datasets could boost economy by over £10 billion a year, new research reveals
NASC conference highlights animal supplement trends amid federal reorganization, tariff concerns
China’s biotech market is staging a comeback that US biotech can only wish for (Subscription required)
